Concepedia

Randomized Trial of Adjuvant Thalidomide Versus Observation in Patients With Completely Resected High-Risk Renal Cell Carcinoma

Vitaly Margulis, Surena F. Matin, Nizar M. Tannir, Pheroze Tamboli, Yu Shen, Marisa Lozano, David A. Swanson, Eric Jonasch, Christopher G. Wood

Urology · 2008 · 37 citations · 24 references

DOIFull text

Open access

Concepts

References

24

Cancer Statistics, 2007

Ahmedin Jemal, Rebecca L. Siegel, Elizabeth Ward et al. · CA A Cancer Journal for Clinicians · 2007 · 7.5K citations · Full text

, , +16

Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma

Bernard Escudier, Tim Eisen, Walter M. Stadler et al. · New England Journal of Medicine · 2007 · 4.8K citations · Full text

, , +11

A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer

James Chih‐Hsin Yang, Leah Haworth, Richard M. Sherry et al. · New England Journal of Medicine · 2003 · 2.7K citations · Full text

, , +17

Thalidomide is an inhibitor of angiogenesis.

Robert J. D’Amato, Michael Loughnan, Evelyn Flynn et al. · Proceedings of the National Academy of Sciences · 1994 · 2.5K citations

, , +14

Sunitinib in Patients With Metastatic Renal Cell Carcinoma

Robert J. Motzer, Brian I. Rini, Ronald M. Bukowski et al. · JAMA · 2006 · 1.2K citations

, , +17